Latinos En Optometr (LEO) makes its launch
Latinos En Optometry, also known as LEO, is launching and wants you to join their community as they expand membership, sponsorship, events, and engagement in the year ahead.
Joseph Carbone named president of Salt Lake City Lions Club
Poll: Have you referred a patient with AMD for a low vision evaluation?
Kicking off AMD Awareness Month, give us your thoughts!
Black EyeCare Perspective appoints new executive director
Essence Johnson, OD, FAAO, Dipl ABO, has been appointed as the first Black EyeCare Perspective executive director.
Positive topline results from Phase 2b clinical trial for meibomian gland dysfunction
The positive 3-month efficacy and safety results from Azura Ophthalmic's Phase 2b study of AZR-MD-001 0.5% in Meibomian Gland Dysfunction (MGD) met its co-primary endpoints.
Alcon completes acquisition of Aerie Pharmaceuticals
This acquisition for Alcon means a growing ophthalmic portfolio of commercial products and development pipeline.
Optometrists and ophthalmologists reflect on the meaning of World Sight Day
In honor of World Sight Day, optometrists and ophthalmologists reflect on what today means to them.
Black EyeCare Perspective to host third annual IMPACT HBCU event
The event is part of the organization's pipeline for Black students into optometry.
NYU Langone Health receives quality and safety awards
Vizient, Inc., designates NYU Langone as number 1 for patient care.
Novartis receives European Commission approval for DME treatment
This latest approval for Beovu (brolucizumab) 6 mg is the second indication granted by the EC, as it was first approved in 2020 for the treatment of AMD.
The Bridge at Vision Expo East: full schedule
An exciting line-up of speakers and panelists is promised for the main-stage destination at VEE 2022.
Bausch + Lomb, Clearside Biomedical launch XIPERE commercially in US
Approved by the FDA last October, XIPERE (triamcinolone acetonide injectable suspension) was approved by the FDA last October as the first and only therapy for treating macular edema associated with uveitis.
FDA approves STAAR Surgical’s EVO Visian ICL for myopia
US commercialization of EVO will begin immediately in select cities across the country.
Visus Therapeutics launches phase 3 trials for presbyopia eye drop
The latest launches of BRIO-I and BRIO-II follow promising topline data from the phase 2 VIVD clinical study evaluating Brimochol PF.
Heru reaches clinical milestone: 10,000 patient eyes examined with AR/VR platform
With its portable capabilities, the Heru platform replaces legacy diagnostic devices and surpasses standard care in cost and size.
Transitions Optical announces new Transitions Academy 2022 dates
Originally postponed due to COVID-19, the annual event will now be held this June at the JW Marriott Grande Lakes in Orlando, Florida.
Orasis Pharmaceuticals completes phase 3 trials for presbyopia candidate
CSF-1 is a preservative-free solution designed as an alternative to reading glasses for patients.
Glaukos launches phase 2 corneal health clinical program for iLink therapy
The company expects to enroll patients diagnosed with keratoconus in two trials at clinical sites in the US, South America, Europe, and Asia.
Topcon introduces SOLOS Automatic Lens Analyzer
SOLOS is automatic lens analyzer that enables advanced, accurate, and efficient lens analysis with one button touch.
ASCO, Johnson & Johnson Vision partner for more diversity in optometry
The unique partnership and corresponding sponsorship is the largest in ASCO’s history.
Théa completes eyecare expansion with Akorn's branded ophthalmic products
The purchase gives Théa ownership over seven products across the therapeutic space, including glaucoma and ocular surface disease.
Kala Pharmaceuticals: EYSUVIS now covered on UnitedHealthcare Commercial, Cigna Medicare
Effective this month, the coverage applies to approximately 70% of all United Healthcare commercial lives.
FDA approves Johnson & Johnson's Acuvue Theravision with Ketotifen contact lens
Daily disposable contact lenses combine with an established antihistamine for the world's first drug-eluting contact lenses.
Aramis Biosciences doses first patient in phase 2 trial for DED treatment
Topline proof-of-concept data are expected by the first quarter of 2023.
CooperVision’s plastic neutral contact lens bank: 1-year results
In the past 12 months, the program has prevented the equivalent of 28 million plastics bottles from polluting the oceans.
Shamir and Alpine extend esports strategic partnership
Shamir joined the Alpine in May 2021 in partnership with Alpine F1 Team to enhance the visual quality and safety of its race team members.
Lumenis partners with Mandy Moore on DED awareness
The actress and singer-songwriter will serves as the brand ambassador for OptiLight, a new dry eye disease treatment.
TearClear’s TC-002 Latanoprost Ophthalmic Solution begins Phase 3 trial
The removal of preservatives may be beneficial for the ocular health of glaucoma patients
Shamir Insight launches two new, updated lens innovations
The optical technology company announced two updates to their product line.
Black EyeCare Perspective launches doctor locator
Black EyeCare Perspective is connecting communities with Black eye care professionals, optometrists and ophthalmologists
2 Clarke Drive Cranbury, NJ 08512